{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:41:07Z","timestamp":1761709267385},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.contraception.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T20:19:29Z","timestamp":1476821969000},"page":"299-305","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prescribing of cyproterone acetate\/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network"],"prefix":"10.1016","volume":"95","author":[{"given":"Luc\u00eda","family":"Cea Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Garc\u00eda Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.10.003_bb0005","author":"CSD Health Research"},{"key":"10.1016\/j.contraception.2016.10.003_bb0010","series-title":"Proc AMIA Annu fall Symp","first-page":"75","article-title":"A language of health in action: read codes, classifications and groupings","author":"Stuart-Buttle","year":"1996"},{"issue":"4","key":"10.1016\/j.contraception.2016.10.003_bb0015","first-page":"251","article-title":"Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"issue":"4","key":"10.1016\/j.contraception.2016.10.003_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.contraception.2016.10.003_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1471-0528.12465","article-title":"Use of prescription contraceptive methods in the UK general population: a primary care study","volume":"121","author":"Cea-Soriano","year":"2014","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.contraception.2016.10.003_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13625187.2013.852170","article-title":"Study of long-acting reversible contraceptive use in a UK primary care database: validation of methodology","volume":"19","author":"Cea Soriano","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2016.10.003_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pds.3710","article-title":"The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network","volume":"24","author":"Cea Soriano","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.contraception.2016.10.003_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/13625187.2014.948613","article-title":"Use of long-acting reversible contraceptives in the UK from 2004 to 2010: analysis using The Health Improvement Network database","volume":"19","author":"Cea Soriano","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2016.10.003_bb0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pds.3877","article-title":"Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom","volume":"25","author":"Cea Soriano","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.contraception.2016.10.003_bb0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pds.3391","article-title":"Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network","volume":"22","author":"Gaist","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.contraception.2016.10.003_bb0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pds.1919","article-title":"Validation of ischemic cerebrovascular diagnoses in The Health Improvement Network (THIN)","volume":"19","author":"Ruig\u00f3mez","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.contraception.2016.10.003_bb0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/dc11-2069","article-title":"Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database","volume":"35","author":"Martin-Merino","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.contraception.2016.10.003_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1783\/147118909787072360","article-title":"Use of contraceptive services in Britain: findings from the second National Survey Of Sexual Attitudes And Lifestyles (Natsal-2)","volume":"35","author":"French","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.10.003_bb0070","article-title":"Prescribing patterns of combined hormonal products containing cyproterone acetate, levonorgestrel and drospirenone in the UK","volume":"20","author":"Cea Soriano","year":"2016","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2016.10.003_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humrep\/deg090","article-title":"Differences in the use of combined oral contraceptives amongst women with and without acne","volume":"18","author":"Seaman","year":"2003","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.contraception.2016.10.003_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jfprhc-2011-100094","article-title":"Co-cyprindiol prescribing in a large, rural general practice in England","volume":"38","author":"Tandy","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"11","key":"10.1016\/j.contraception.2016.10.003_bb0085","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1503\/cmaj.050567","article-title":"Medicine by media: did a critical television documentary affect the prescribing of cyproterone\u2013estradiol (Diane-35)?","volume":"173","author":"Mintzes","year":"2005","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.contraception.2016.10.003_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40264-014-0149-8","article-title":"Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals","volume":"37","author":"Gourbil","year":"2014","journal-title":"Drug Saf"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241630453X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241630453X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T13:20:50Z","timestamp":1536326450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241630453X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S001078241630453X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.10.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing of cyproterone acetate\/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}